• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于阿尔茨海默病成像的PET tau示踪剂[(11)C]PBB3的合成。

Synthesis of a PET tau tracer [(11)C]PBB3 for imaging of Alzheimer's disease.

作者信息

Wang Min, Gao Mingzhang, Xu Zhidong, Zheng Qi-Huang

机构信息

Department of Radiology and Imaging Sciences, Indiana University School of Medicine, 1345 West 16th Street, Room 202, Indianapolis, IN 46202, USA.

Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of Ministry of Education, College of Chemistry and Environmental Science, Hebei University, Baoding, Hebei 071002, China.

出版信息

Bioorg Med Chem Lett. 2015 Oct 15;25(20):4587-92. doi: 10.1016/j.bmcl.2015.08.053. Epub 2015 Aug 20.

DOI:10.1016/j.bmcl.2015.08.053
PMID:26323870
Abstract

The authentic standard PBB3 and its precursor N-desmethyl-PBB3 as well as TBS-protected N-desmethyl-PBB3 precursor for radiolabeling were synthesized from 5-bromo-2-nitropyridine, acrolein diethyl acetal, 6-methoxy-2-methylbenzothiazole, and diethylchlorophosphate with overall chemical yield 1% in six steps, 2% in five steps, and 1% in six steps, respectively. [(11)C]PBB3 was prepared from either desmethyl-PBB3 or TBS-protected desmethyl-PBB3 with [(11)C]CH3OTf through N-[(11)C]methylation and isolated by HPLC combined with SPE in 20-25% and 15-20% radiochemical yield, respectively, based on [(11)C]CO2 and decay corrected to end of bombardment (EOB). The radiochemical purity was >99%, and the specific activity at EOB was 370-1110 GBq/μmol with a total synthesis time of ~40-min from EOB.

摘要

authentic标准品PBB3及其前体N-去甲基-PBB3以及用于放射性标记的TBS保护的N-去甲基-PBB3前体由5-溴-2-硝基吡啶、丙烯醛二乙缩醛、6-甲氧基-2-甲基苯并噻唑和二氯磷酸二乙酯合成,总化学产率分别为6步反应1%、5步反应2%和6步反应1%。[(11)C]PBB3由去甲基-PBB3或TBS保护的去甲基-PBB3与[(11)C]CH3OTf通过N-[(11)C]甲基化反应制备,并通过HPLC结合SPE分离,基于[(11)C]CO2并校正到轰击结束(EOB)时的放射性化学产率分别为20%-25%和15%-20%。放射性化学纯度>99%,EOB时的比活度为370-1110 GBq/μmol,从EOB开始的总合成时间约为40分钟。

相似文献

1
Synthesis of a PET tau tracer [(11)C]PBB3 for imaging of Alzheimer's disease.用于阿尔茨海默病成像的PET tau示踪剂[(11)C]PBB3的合成。
Bioorg Med Chem Lett. 2015 Oct 15;25(20):4587-92. doi: 10.1016/j.bmcl.2015.08.053. Epub 2015 Aug 20.
2
Radiosynthesis, photoisomerization, biodistribution, and metabolite analysis of 11C-PBB3 as a clinically useful PET probe for imaging of tau pathology.11C-PBB3作为用于tau病理学成像的临床可用PET探针的放射性合成、光异构化、生物分布及代谢物分析。
J Nucl Med. 2014 Sep;55(9):1532-8. doi: 10.2967/jnumed.114.139550. Epub 2014 Jun 24.
3
Concise and high-yield synthesis of T808 and T808P for radiosynthesis of [(18)F]-T808, a PET tau tracer for Alzheimer's disease.用于合成 [(18)F]-T808 的 PET tau 示踪剂 T808 和 T808P 的简洁高产合成。
Bioorg Med Chem Lett. 2014 Jan 1;24(1):254-7. doi: 10.1016/j.bmcl.2013.11.025. Epub 2013 Nov 20.
4
Fully automated synthesis of [(18)F]T807, a PET tau tracer for Alzheimer's disease.用于阿尔茨海默病的正电子发射断层显像(PET)tau蛋白示踪剂[(18)F]T807的全自动化合成
Bioorg Med Chem Lett. 2015 Aug 1;25(15):2953-7. doi: 10.1016/j.bmcl.2015.05.035. Epub 2015 May 21.
5
Radiosynthesis and quality control testing of the tau imaging positron emission tomography tracer [ F]PM-PBB3 for clinical applications.用于临床应用的tau 成像正电子发射断层扫描示踪剂 [ F]PM-PBB3 的放射性合成和质量控制测试。
J Labelled Comp Radiopharm. 2021 Mar;64(3):109-119. doi: 10.1002/jlcr.3890. Epub 2020 Nov 7.
6
Synthesis of [(11)C]GSK1482160 as a new PET agent for targeting P2X(7) receptor.新型正电子发射断层显像(PET)靶向P2X(7)受体显像剂[(11)C]GSK1482160的合成
Bioorg Med Chem Lett. 2015 May 1;25(9):1965-70. doi: 10.1016/j.bmcl.2015.03.021. Epub 2015 Mar 14.
7
Synthesis of [¹¹C]PBR06 and [¹⁸F]PBR06 as agents for positron emission tomographic (PET) imaging of the translocator protein (TSPO).[¹¹C]PBR06 和 [¹⁸F]PBR06 的合成作为正电子发射断层扫描 (PET) 成像转位蛋白 (TSPO) 的示踪剂。
Steroids. 2011 Nov;76(12):1331-40. doi: 10.1016/j.steroids.2011.06.012. Epub 2011 Jul 3.
8
Dual tracer tau PET imaging reveals different molecular targets for C-THK5351 and C-PBB3 in the Alzheimer brain.双示踪剂 tau PET 成像显示 C-THK5351 和 C-PBB3 在阿尔茨海默病大脑中针对不同的分子靶点。
Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1605-1617. doi: 10.1007/s00259-018-4012-5. Epub 2018 May 12.
9
Synthesis of [11C]CX-6258 as a new PET tracer for imaging of Pim kinases in cancer.新型正电子发射断层显像(PET)示踪剂[11C]CX-6258的合成,用于癌症中Pim激酶的成像。
Bioorg Med Chem Lett. 2015 Sep 15;25(18):3831-5. doi: 10.1016/j.bmcl.2015.07.061. Epub 2015 Jul 26.
10
The first synthesis of [11C]J147, a new potential PET agent for imaging of Alzheimer's disease.[11C]J147 的首次合成,一种用于阿尔茨海默病成像的新型潜在 PET 示踪剂。
Bioorg Med Chem Lett. 2013 Jan 15;23(2):524-7. doi: 10.1016/j.bmcl.2012.11.031. Epub 2012 Nov 22.

引用本文的文献

1
Advance and Prospect of Positron Emission Tomography in Alzheimer's disease research.正电子发射断层扫描在阿尔茨海默病研究中的进展与展望
Mol Psychiatry. 2025 Jun 21. doi: 10.1038/s41380-025-03081-2.
2
Nitropyridines in the Synthesis of Bioactive Molecules.生物活性分子合成中的硝基吡啶
Pharmaceuticals (Basel). 2025 May 7;18(5):692. doi: 10.3390/ph18050692.
3
Strategies of positron emission tomography (PET) tracer development for imaging of tau and α-synuclein in neurodegenerative disorders.用于神经退行性疾病中tau蛋白和α-突触核蛋白成像的正电子发射断层扫描(PET)示踪剂开发策略。
RSC Med Chem. 2024 Nov 20. doi: 10.1039/d4md00576g.
4
Inflammasome links traumatic brain injury, chronic traumatic encephalopathy, and Alzheimer's disease.炎性小体将创伤性脑损伤、慢性创伤性脑病和阿尔茨海默病联系起来。
Neural Regen Res. 2025 Jun 1;20(6):1644-1664. doi: 10.4103/NRR.NRR-D-24-00107. Epub 2024 Jul 10.
5
Biomarkers and Target-Specific Small-Molecule Drugs in Alzheimer's Diagnostic and Therapeutic Research: From Amyloidosis to Tauopathy.阿尔茨海默病诊断与治疗研究中的生物标志物及靶向小分子药物:从淀粉样病变到tau蛋白病变
Neurochem Res. 2024 Sep;49(9):2273-2302. doi: 10.1007/s11064-024-04178-w. Epub 2024 Jun 6.
6
Methemoglobinemia and Delayed Encephalopathy After 5-Bromo-2-Nitropyridine Poisoning: A Rare Case Report.5-溴-2-硝基吡啶中毒致高铁血红蛋白血症和迟发性脑病:一例罕见病例报告。
Front Public Health. 2022 Jul 7;10:942003. doi: 10.3389/fpubh.2022.942003. eCollection 2022.
7
Quantitative analysis of regional distribution of tau pathology with 11C-PBB3-PET in a clinical setting.在临床环境下用 11C-PBB3-PET 进行 tau 病理学的区域分布定量分析。
PLoS One. 2022 Apr 11;17(4):e0266906. doi: 10.1371/journal.pone.0266906. eCollection 2022.
8
(F)-Fluorodeoxyglucose positron emission tomography/magnetic resonance imaging assessment of hypometabolism patterns in clinical phenotypes of suspected corticobasal degeneration.(F)-氟脱氧葡萄糖正电子发射断层扫描/磁共振成像对疑似皮质基底节变性临床表型中低代谢模式的评估
World J Nucl Med. 2020 Oct 7;20(2):176-184. doi: 10.4103/wjnm.WJNM_62_20. eCollection 2021 Apr-Jun.
9
Synthesis and Assessment of Novel Probes for Imaging Tau Pathology in Transgenic Mouse and Rat Models.新型探针的合成与评估用于转基因鼠和鼠模型中的 Tau 病理学成像。
ACS Chem Neurosci. 2021 Jun 2;12(11):1885-1893. doi: 10.1021/acschemneuro.0c00790. Epub 2021 Mar 10.
10
Tau PET imaging: present and future directions.tau蛋白正电子发射断层显像:现状与未来发展方向
Mol Neurodegener. 2017 Feb 20;12(1):19. doi: 10.1186/s13024-017-0162-3.